Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2015-05-01
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a 60-day randomized single blinded parallel group study. After 42 days, all use of interventional products were discontinued, and the participants returned to the clinical center at day 60 for final measurements. The primary outcomes assessed in this study were the differences in gingival index (GI) and bleeding on probing (BOP) from baseline to 42 \& 60 days. The secondary outcomes are tooth whitening, oral malodor, pocket depth and plaque amount.
It is hypothesized that participants using the gingival health product with the GLO Device will experience greater reductions in GI \& BOP measurements than the control group, as well as participants using the gingival health product on a toothbrush alone.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Efficacy of a Gum Health Formulation on Teeth Whitening in Patients With Gingivitis and Periodontitis
NCT02906982
A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks
NCT04050722
Efficacy of Teeth Whitening Product Offerings in Adults
NCT04124068
A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods
NCT07211061
A Bleeding-Model Clinical Study
NCT05916508
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gingival health formulation in accelerating device
The interventional gingival health formulation is applied to the participant's mouth by means of an intra-oral accelerating device for a single eight-minute application, daily. Participants were instructed to brush their teeth with an OTC toothpaste twice daily, morning and night.
Gingival health formulation in an accelerating device
The intervention is a gingival health formulation for soft tissue maintenance, oral malodor and gentle teeth whitening to be used with the GLO Science Device
OTC fluoride toothpaste
OTC anti-cavity toothpaste containing fluoride and sodium monofluorophosphate.
Gingival health formulation on a toothbrush
The interventional gingival health formulation is applied to the participant's mouth by means of a toothbrush and OTC toothpaste, together with the formulation in equal amounts, for two-minute applications twice daily, morning and night.
Gingival health formulation on a toothbrush
The intervention is a gingival health formulation for soft tissue maintenance, oral malodor and gentle teeth whitening to be used on a toothbrush together with toothpaste.
OTC fluoride toothpaste
OTC anti-cavity toothpaste containing fluoride and sodium monofluorophosphate.
Control group (Split mouth design)
The control group did not receive the interventional gingival health formulation. Participants were instructed to brush their teeth with a toothbrush and OTC toothpaste twice daily, morning and night. In addition, participants were instructed to floss only half of their mouth daily, having the non-flossed half serve as an untreated comparative control of toothbrushing alone.
OTC fluoride toothpaste
OTC anti-cavity toothpaste containing fluoride and sodium monofluorophosphate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gingival health formulation in an accelerating device
The intervention is a gingival health formulation for soft tissue maintenance, oral malodor and gentle teeth whitening to be used with the GLO Science Device
Gingival health formulation on a toothbrush
The intervention is a gingival health formulation for soft tissue maintenance, oral malodor and gentle teeth whitening to be used on a toothbrush together with toothpaste.
OTC fluoride toothpaste
OTC anti-cavity toothpaste containing fluoride and sodium monofluorophosphate.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good general health as evidenced by the medical history
* Between 18 and 55 years of age
* Male or female
* Minimum of 20 teeth, excluding crowns and third molar teeth
* Mean whole mouth Gingival Index \>/=2.0 at baseline; sites with \</=7mm pocket depth
* Willing to abstain from all oral hygiene procedures 12-18 hours prior to clinical visits
* Willing to abstain from eating and drinking for 2 hours prior to clinical visits, only drinking water is allowed
* Willing to abstain from chewing gums, oral whitening products, mouthwashes and tobacco products for the study duration
* Able to understand and follow study directions
Exclusion Criteria
* Diagnosed with diabetes
* Presence of orthodontic appliances
* Presence of large restorations, crown or veneer at the anterior of both upper and lower teeth (including premolar teeth)
* A soft or hard tissue tumor of the oral cavity
* Carious lesions requiring immediate treatment
* Patients with severe internal (tetracycline stains) and external discoloration (fluorosis)
* Patients with severe chronic periodontitis, aggressive periodontitis, acute necrotizing ulcerative gingivitis, or generalized gingival recession \>2mm as evidenced by clinical oral exam
* Pregnant or breast-feeding women
* Allergy to home bleaching products such as hydrogen peroxide and carbide peroxide
* Use of antibiotics within 3 months of enrollment
* History of drug use that is associated with gum overgrowth (i.e., Dilantin, nifedipine, etc.)
* Chronic use of medication such as steroids, anti-coagulant medications, immunosuppressant medication or any other medications or medical conditions that in the opinion of the Investigator would interfere with the evaluation or confound interpretation of the study results. Use of low dose of ASA (\<325mg) is permitted.
* Medical condition which requires pre-medication prior to dental visits/procedures
* Current smoking and former smoking within one year of enrollment
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Forsyth Institute
OTHER
Glo Science, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hatice Hasturk, DDS, PhD
Role: PRINCIPAL_INVESTIGATOR
The Forsyth Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Forsyth Institute
Cambridge, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GLO-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.